Dr. Bendjama is a Project Leader in Personalized cancer vaccines at Transgene. He is an experienced biomarker scientist with a strong entrepreneurial spirit and a positive attitude, now working on the development of personalized immunotherapies for cancer.
He has 10 years of experience in biomarker and in vitro diagnostic medical device R&D in CRO and Pharma and he is familiar with various therapeutic areas: Immunology, Cardiovascular, and oncology from early research to Phase II studies and device registration.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)